Ashkenazi A, Dixit VM. 1999. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11(2): 255-260.
Chen K, Zhao H, Hu Z, Wang LE, Zhang W, Sturgis EM, Wei Q. 2008. CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 14(19): 6343-6349.
Deng B, Liu F, Luo L, Wei Y, Li B, Yang H. 2016. CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population. Tumour Biol 37(7): 8985-8991.
Fang Y, Qiu J, Jiang ZB, Xu SR, Zhou ZH, He RL. 2016. Associations of Caspase-3 gene polymorphism with lumbar disc herniation. Kaohsiung J Med Sci 32(11): 552-558.
Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407(6805): 770-776.
Jang JS, Kim KM, Choi JE, Cha SI, Kim CH, Lee WK, Kam S, et al. 2008. Identification of polymorphisms in the Caspaseā3 gene and their association with lung cancer risk. Mol Carcinog 47(5): 383-390.
Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N. 1999. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 6(1): 33-40.
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91(4): 479-489.
Li B, Liu H, Gong F, Sun P, Yan Y, Jia B. 2014. Molecular epidemiologic correlation analysis between caspase3 gene polymorphism and gastric cancer susceptibility. Cell Biochem Biophys 70(3): 1647-1653.
Liu ZF, Aikenmu ALJ, Zhao J, Meng QC, Fang R. 2015. Influence of ERCC2 gene Polymorphisms on the Treatment outcome of osteosarcoma. Genet Mol Res 14(4):12967-12972.
Mittal RD, Mittal T, Singh AK, Mandal RK. 2012. Association of caspases with an increased prostate cancer risk in north Indian population. DNA Cell Biol31(1): 67-73.
Saleh Tabari Y, Bakhshi O, Mohammadpour A, Hoseini V, Haghi Aminjan H, Shokrzadeh M. 2018. Evaluation of NQO1 Polymorphism in Gastric Adenocarcinoma. J Mazandaran Univ Med Sci 27(157): 230-235.
Scorrano L, Korsmeyer SJ. 2003. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304(3): 437-444.
Shokrzadeh M, Mohammadpour A, Tabari YS, Parvizi Almani S. 2017. Investigating the Distribution of ERCC2 (rs13181) Gene Polymorphism in Gastric Cancer Patients in Mazandaran: A Case-control Study. J Genet Resour 3(1): 54-60.
Shokrzadeh M, Fattahi I, Mohammadpour A, Mashhadban AH. 2017. Presence of CagA Gene and Its Antibiotic Resistance Pattern in Helicobacter Pylori Isolates. J Mazandaran Univ Med Sci27(154): 60-72.
van Loo G, Saelens X, Van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. 2002. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9(10): 1031-1042.
Wu Z, Li Y, Li S, Zhu L, Li G, Yu Z, Zhao X, et al. 2013. Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer. Med Oncol 30(3): 565.
Yan S, Li YZ, Zhu XW, Liu CL, Wang P, Liu YL. 2013. HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk. Genet Mol Res 12(2): 1561-1573.
Yoo SS, Choi JE, Lee WK, Choi YY, Kam S, Kim MJ, Jeon HS, et al. 2009. Polymorphisms in the CASPASE genes and survival in patients with early-stage non–small-cell lung cancer. J Clin Oncol 27(34): 5823-5829.